Cargando…

Advancing precision oncology in metastatic colorectal cancer: The food and drug administration approval of foundation one liquid CDx as a companion diagnostic a correspondence

Detalles Bibliográficos
Autores principales: Shahnoor, Syeda, Mansha, Manahil, Farhat, Solay, Maryyum, Adeena, Khan, Adil Naseer, Khan, Abdul Moiz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521303/
https://www.ncbi.nlm.nih.gov/pubmed/37767464
http://dx.doi.org/10.1177/20363613231204798
_version_ 1785110100423213056
author Shahnoor, Syeda
Mansha, Manahil
Farhat, Solay
Maryyum, Adeena
Khan, Adil Naseer
Khan, Abdul Moiz
author_facet Shahnoor, Syeda
Mansha, Manahil
Farhat, Solay
Maryyum, Adeena
Khan, Adil Naseer
Khan, Abdul Moiz
author_sort Shahnoor, Syeda
collection PubMed
description
format Online
Article
Text
id pubmed-10521303
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-105213032023-09-27 Advancing precision oncology in metastatic colorectal cancer: The food and drug administration approval of foundation one liquid CDx as a companion diagnostic a correspondence Shahnoor, Syeda Mansha, Manahil Farhat, Solay Maryyum, Adeena Khan, Adil Naseer Khan, Abdul Moiz Rare Tumors Letter to the Editor SAGE Publications 2023-09-25 /pmc/articles/PMC10521303/ /pubmed/37767464 http://dx.doi.org/10.1177/20363613231204798 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Letter to the Editor
Shahnoor, Syeda
Mansha, Manahil
Farhat, Solay
Maryyum, Adeena
Khan, Adil Naseer
Khan, Abdul Moiz
Advancing precision oncology in metastatic colorectal cancer: The food and drug administration approval of foundation one liquid CDx as a companion diagnostic a correspondence
title Advancing precision oncology in metastatic colorectal cancer: The food and drug administration approval of foundation one liquid CDx as a companion diagnostic a correspondence
title_full Advancing precision oncology in metastatic colorectal cancer: The food and drug administration approval of foundation one liquid CDx as a companion diagnostic a correspondence
title_fullStr Advancing precision oncology in metastatic colorectal cancer: The food and drug administration approval of foundation one liquid CDx as a companion diagnostic a correspondence
title_full_unstemmed Advancing precision oncology in metastatic colorectal cancer: The food and drug administration approval of foundation one liquid CDx as a companion diagnostic a correspondence
title_short Advancing precision oncology in metastatic colorectal cancer: The food and drug administration approval of foundation one liquid CDx as a companion diagnostic a correspondence
title_sort advancing precision oncology in metastatic colorectal cancer: the food and drug administration approval of foundation one liquid cdx as a companion diagnostic a correspondence
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521303/
https://www.ncbi.nlm.nih.gov/pubmed/37767464
http://dx.doi.org/10.1177/20363613231204798
work_keys_str_mv AT shahnoorsyeda advancingprecisiononcologyinmetastaticcolorectalcancerthefoodanddrugadministrationapprovaloffoundationoneliquidcdxasacompaniondiagnosticacorrespondence
AT manshamanahil advancingprecisiononcologyinmetastaticcolorectalcancerthefoodanddrugadministrationapprovaloffoundationoneliquidcdxasacompaniondiagnosticacorrespondence
AT farhatsolay advancingprecisiononcologyinmetastaticcolorectalcancerthefoodanddrugadministrationapprovaloffoundationoneliquidcdxasacompaniondiagnosticacorrespondence
AT maryyumadeena advancingprecisiononcologyinmetastaticcolorectalcancerthefoodanddrugadministrationapprovaloffoundationoneliquidcdxasacompaniondiagnosticacorrespondence
AT khanadilnaseer advancingprecisiononcologyinmetastaticcolorectalcancerthefoodanddrugadministrationapprovaloffoundationoneliquidcdxasacompaniondiagnosticacorrespondence
AT khanabdulmoiz advancingprecisiononcologyinmetastaticcolorectalcancerthefoodanddrugadministrationapprovaloffoundationoneliquidcdxasacompaniondiagnosticacorrespondence